Abstract
Determination of plasma protein binding is important in drug discovery and development for developing PK-PD relationships, and projecting clinical doses because the free drug concentration at the site of action is responsible for the pharmacological activity. This chapter will describe various methods commonly used for the in vitro determination of plasma protein binding including classical equilibrium dialysis (CED), rapid equilibrium dialysis (RED), and ultrafiltration Nonspecific binding and mass balance methods used to recover or prevent the loss of compound due to binding to the wall and/or membrane of the apparatus will be briefly discussed as well. Finally, the techniques will be discussed in relation to the type of study required and the method of analysis of both the bound (plasma) and free-fraction (buffer) components and the analytical procedures needed for the quantification of concentrations in these matrices. Techniques using both radiolabeled and cold compounds will be presented as both are usually available at the early or late discovery phases and employ different methods of analysis.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Bowers W, Fulton S, Thompson J (1984) Ultrafiltration vs equilibrium dialysis for determination of free fraction. Clin Pharmacokinet 9(suppl 1):49–60
Smith DA, Kerns EH (2010) The effect of plasma protein binding on in vivo efficacy: misconceptions in drug discovery. Nat Rev Drug Discov 9:929–939
Curan R, Claxton C, Hutchinson L, Harridine P, Martin I, Littlewood P (2011) Control and measurement of plasma pH in equilibrium dialysis: influence on drug plasma protein binding. Drug Metab Dispos 39(3):551–557
Kariv I, Cao H, Oldenburg K (2000) Development of a high throughput equilibrium dialysis method. J Pharm Sci 90(5):580–587
Di L, Umland J, Trapa P, Maurer T (2012) Impact of recovery on fraction unbound using equilibrium dialysis. J Pharm Sci 101(3):1327–1335
Waters N, Jones R, Williams G, Sohal B (2008) Validation of a rapid equilibrium dialysis approach for the measurement of plasma protein binding. J Pharm Sci 97(10):4586–4595
Acknowledgements
The views expressed here are solely those of the author and do not reflect the opinions of Janssen Research & Development, LLC.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer Science+Business Media New York
About this protocol
Cite this protocol
Kalamaridis, D., Patel, N. (2014). Assessment of Drug Plasma Protein Binding in Drug Discovery. In: Caldwell, G., Yan, Z. (eds) Optimization in Drug Discovery. Methods in Pharmacology and Toxicology. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-62703-742-6_2
Download citation
DOI: https://doi.org/10.1007/978-1-62703-742-6_2
Published:
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-62703-741-9
Online ISBN: 978-1-62703-742-6
eBook Packages: Springer Protocols